M&As this week: JW Pharmaceutical, Lonza, Karo Intressenter
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment.
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment.
Indian bio-pharmaceuticals developer Strides Shasun has signed an agreement with Apotex to merge with the latter’s Australian subsidiary, Apotex.
Indian biopharmaceutical company MannKind has agreed to sign a marketing and distribution agreement with Cipla for the inhaled insulin…
Canadian oral drug delivery company IntelGenx Technologies plans to issue 300 units priced at $10,000 a unit in a…
United Therapeutics Corporation has agreed to acquire SteadyMed for $216m.
US-based biotechnology company CTD Holdings has completed issuing 20,000 units of series B convertible preferred stock for the development…
AstraZeneca has agreed to purchase an additional 5.7% stake in Circassia Pharmaceuticals in a cash transaction.
US-based biopharmaceutical company Clovis Oncology has announced the pricing for its proposed issue of convertible senior notes due 1…
Wacker Biotech has completed the acquisition of Synco Bio Partners, with the objective of expanding its portfolio and further…
Thank you for subscribing to Pharmaceutical Technology